Olaparib improved invasive disease-free survival, distant disease-free survival, and overall survival in high-risk ...
Neoadjuvant SHR-A1811 showed similar pathologic complete response rates to the standard 4-drug regimen in patients with ...
The FDA approved inavolisib for triplet combination use for treatment of PIK3CA-mutated locally advanced or metastatic ...
The following is a summary of “Higher Versus Lower Protein Delivery in Critically Ill Patients: A Systematic Review and ...
The following is a summary of “Clinical and ultrasound characteristics in patients with sars-cov-2 pneumonia, associated with ...
The following is a summary of “Dynamic assessment of signal entropy for prognostication and secondary brain insult detection ...
The following is a summary of “lncRNA six3os1 diagnoses acute stroke, predicts disease severity, and predicts post-stroke ...
The phase 3 SONIA trial showed deferring CDK4/6 inhibitor treatment may not compromise HRQOL in patients with HR-positive/HER2-negative advanced breast cancer.
The following is a summary of “Expanded and independent validation of the NoMoFA scale for Parkinson’s disease: the Italian ...
Related Cognitive Impairment and Changes in Neural Network Dynamics: A Systematic Review,” published in the December 2024 ...
The following is a summary of “Prenatal ultrasound phenotype of fetuses with recurrent 1q21.1 deletion and duplication ...
The following is a summary of “Advancing the timing of drainage removal: a comprehensive analysis of different drainage ...